Treatment Response Optimized Clinical Decision Support AI System via Digital Twin Simulation
Quick Answer
The proposed Clinical Decision Support AI System integrates Treatment Effect estimation, a patient Digital Twin, and Reinforcement Learning for real-time adaptive treatment recommendations.
Quick Take
The proposed Clinical Decision Support AI System integrates Treatment Effect estimation, a patient Digital Twin, and Reinforcement Learning for real-time adaptive treatment recommendations. Validated on ovarian cancer data from TCGA, it outperforms standard methods in effectiveness and stability while maintaining low latency and requiring minimal expert intervention.
Key Points
- Integrates Treatment Effect estimation and patient Digital Twin for personalized medicine.
- Utilizes Reinforcement Learning for sequential decision-making in treatment recommendations.
- Demonstrated superior effectiveness compared to standard computational baselines.
- Maintains low latency with minimal need for clinician consultation.
- Validated using both synthetic simulations and real-world clinical data.
Paper Resources
Article Content
From source RSS / original summaryarXiv:2606. 17405v1 Announce Type: new Abstract: Clinical decision support AI systems (CDSASs) must adapt to evolving patient conditions in real-time while adhering to strict safety constraints. We present an online adaptive framework that integrates Treatment Effect (TE) estimation to quantify clinical benefits, a patient Digital Twin (DT) to simulate treatment trajectories, and Reinforcement Learning (RL) for sequential decision-making.
The AI system is initially trained on historical medical records and operates in a continuous learning loop. To ensure safety, a rule-based module monitors vital signs and blocks contraindicated treatments. Cases with strong internal model disagreement are flagged for clinician review, simulated in our experiments via a pre-trained outcome model. We validate our framework using both a synthetic clinical simulator and a real-world ovarian cancer dataset from The Cancer Genome Atlas (TCGA).
In both simulated and clinical settings, our method demonstrated superior effectiveness and stability in recommending treatments compared to standard computational baselines. Furthermore, the AI system maintains low latency and requires expert consultation for only a minority of cases in our experimental validation, demonstrating its potential as a safe, clinician-supervised tool for personalized medicine that continuously improves through practical use.
Reader Mode unavailable (could not extract clean content).
Want this in your inbox every morning?
Daily brief at your local 8am — bilingual EN/中文, free.
More from arXiv cs.AI
See more →Arbor: Tree Search as a Cognition Layer for Autonomous Agents
Arbor introduces a multi-agent framework utilizing structured tree search for optimizing LLM inference, achieving up to 193% throughput-latency improvement compared to vendor-optimized systems. It employs an Orchestrator and Critic agent for stability and coordination, demonstrating hardware-agnostic performance with minimal variance.